 Geneva, Switzerland and Boston, MA May 31 , 202 1 ObsEva SA NASDAQ: OBSV SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced that shareholders approved all Board proposals at its 2021 Annual General Meeting held on May 28, 2021. 